Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
Fujita K, Matsushita Y, Toyoda S, Kojima T, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Tatarano S, Masui K, Nakamura E, Kaneko T, Kitano G, Motoshima T, Shiraishi, Kira S, Murashima T, Hara H, Matsumura, Nishiyama N, Miyake H, Kitamura H, Uemura H. Fujita K, et al. Among authors: murashima t. World J Urol. 2024 Sep 26;42(1):536. doi: 10.1007/s00345-024-05252-2. World J Urol. 2024. PMID: 39325218
Metastasis of malignant melanoma to urinary tract: a case report.
Ueno T, Kiwaki T, Betsunoh H, Ito K, Murashima T, Fujii M, Nagai T, Mukai S, Sawada A, Kamoto T. Ueno T, et al. Among authors: murashima t. J Med Case Rep. 2024 Aug 28;18(1):396. doi: 10.1186/s13256-024-04716-8. J Med Case Rep. 2024. PMID: 39192344 Free PMC article.
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Tomida R, Takahashi M, Matsushita Y, Kojima T, Yamana K, Kandori S, Bando Y, Nishiyama N, Yamashita S, Taniguchi H, Monji K, Ishiyama R, Tatarano S, Masui K, Matsuda A, Kaneko T, Motoshima T, Shiraishi Y, Kira S, Murashima T, Hara H, Matsumura M, Kitamura H, Miyake H, Furukawa J; Japanese Urological Oncology Group. Tomida R, et al. Among authors: murashima t. Clin Genitourin Cancer. 2024 Jun;22(3):102094. doi: 10.1016/j.clgc.2024.102094. Epub 2024 Apr 15. Clin Genitourin Cancer. 2024. PMID: 38714434
Paratesticular cellular angiofibroma: a case report.
Murashima T, Kida K, Gi T, Hida T, Fujii M, Nagai T, Takamori H, Mukai S, Sato Y, Kamoto T. Murashima T, et al. J Med Case Rep. 2024 Apr 11;18(1):170. doi: 10.1186/s13256-024-04499-y. J Med Case Rep. 2024. PMID: 38600580 Free PMC article.
Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.
Miyamoto Y, Kawasoe C, Ito K, Oguri N, Murashima T, Kamibeppu T, Nagai T, Takamori H, Kamimura T, Mukai S, Sato Y, Kamoto T. Miyamoto Y, et al. Among authors: murashima t. J Med Case Rep. 2023 Dec 22;17(1):524. doi: 10.1186/s13256-023-04288-z. J Med Case Rep. 2023. PMID: 38129899 Free PMC article.
47 results